首页> 外文期刊>Blood purification >Survival of Vascular Accesses in Chronic Hemodialysis Patients
【24h】

Survival of Vascular Accesses in Chronic Hemodialysis Patients

机译:慢性血液透析患者血管进入的存活

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background/Aims: Vascular access (VA) is the highest risk factor for blood infections, hospitalization, and mortality of patients undergoing hemodialysis (HD). The risk of mortality while using a catheter is greater than that while using grafts. The objective of this article is to know the survival rate in relation to the type of VA. Methods: A retrospective cohort of HD patients was studied. The data gathered included age, gender, first VA at the surrogate site, days between the first and second access, number of accesses, and anatomical site of VA placement. Mean differences were estimated using chi(2) or Student's t test. Survival was calculated using the Kaplan-Meier curves and included in tables. Statistical significance was established as p < 0.05. The statistical computer software package SPSSw v25 was used for the analysis. Results: A total of 896 patients were included with a mean age of 47.88 years (SD +/- 16.52), the duration of the first VA was 398.81 days (+/- 565.79), the mean number of VAs used was 2.26 (+/- 1.15), and the median time undergoing HD was 728.73 days. The duration of catheter placement was 330.42 days, and 728.60 days for fistula use (p = 0.001). The mean number of days of renal replacement was 611.59 days for catheter and 1,495.25 days for internal arteriovenous fistula (IAVF) patients (p = 0.001). Conclusions: The survival of the initial VA is greater for the IAVF, followed by the tunneled catheters and the lowest by the non-tunneled catheters, which continue to be frequently used in our setting.
机译:背景/目的:血管接入(Va)是血液感染,住院治疗和血液透析性患者(HD)的死亡率的最高风险因素。使用导管的同时大于使用移植物的同时大的死亡风险大。本文的目的是了解与VA类型相关的生存率。方法:研究了HD患者的回顾性群组。收集的数据包括年龄,性别,第一个VA在代理站点,第一和第二次访问的天数,访问数量和VA放置的解剖站点。使用CHI(2)或学生的T检验估计平均差异。使用Kaplan-Meier曲线计算生存并包含在表中。统计学意义建立为P <0.05。统计计算机软件包SPSSW V25用于分析。结果:共有896名患者,平均年龄为47.88岁(SD +/- 16.52),第一个VA的持续时间为398.81天(+/- 565.79),所使用的VAS的平均数量为2.26(+ / - 1.15),中位数的HD为728.73天。导管置入的持续时间为330.42天,瘘管使用728.60天(P = 0.001)。导管的肾置换天数为611.59天,内部动静脉瘘(IAVF)患者的1,495.25天(P = 0.001)。结论:IAVF的初始VA的存活率更大,其次是隧道导管,由非隧道导管最低,该导管继续经常在我们的环境中使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号